Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides

Journal of Peptide Research

Volumn 50, Issue 4, 1997, Pages 279-285

  Shin, Song Yub ^a   Lee, Myung Kyu ^a   Kim, Kil Lyong ^a   Hahm, Kyung Soo ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Antitumor activity; Hemolytic activity; Hybrid peptides; helicity

Indexed keywords

ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; CECROPIN A; HYBRID PROTEIN; MAGAININ 2; MELITTIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMOLYSIS; HYDROPHOBICITY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TARGET CELL;

EID: 0000378555     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3011.1997.tb01469.x     Document Type: Article

References (22)

1. Zasloff, M. (1987) Proc. Natl. Acad. Sci. USA 84, 5449-5453
2. Soravia, E., Martini, G. & Zasloff, M. (1988) FEBS Lett 228, 337-340
3. Steiner, H., Hultmark, D., Engstrom, A., Bennich, H. & Boman, H.G. (1981) Nature 292, 246-248
4. von Hofsten, P., Faye, I., Kockum, K., Lee, J.Y., Xanthopouls, K.G., Boman, A., Boman,G., Engstron, A. Andreu, D. & Merrifield, R.B. (1985) Proc. Natl. Acad. Sci. USA 82, 2240-2243
5. Lee, J.Y., Boman, A., Sun, C., Andersson, M., Jornvall, H., Mutt, V. & Boman, H.G. (1989) Proc. Natl. Acad. Sci. USA 86, 9195-9162
6. Tosteson, M.T., Holmes, S.J., Razin, M. & Tosteson, D.C. (1985) J. Membr. Biol. 87, 35-44
7. Boman, H.G., Wade, D., Boman, A., Wahlin, B. & Merrifield, R.B. (1989) FEBS Lett. 259, 103-106
8. Andreu, D., Ubach, J., Boman, A., Wahlin, D., Wade, D., Merrifield, R.B. & Boman, H.G. (1992) FEBS Lett. 296, 190-194
9. Wade, D., Andreu, D., Mitchell, S.A., Silveira, A.M.V., Boman, A., Boman, H.G. & Merrifield, R.B. (1992) Int. J. Pept. Protein Res 40, 429-436
10. Ohsaki, Y., Gazdar, A.F., Chen, H.C. & Johnson, B.E. (1993) Cancer Res 52, 3534-3538
11. Westerhoff, H.U., Juretic, U., Hendler, R.W. & Zasloff, M. (1989) Proc. Natl. Acad. Sci. USA 86, 6597-6601
12. Bondle, S.E., & Houghten, R.A. (1992) Biochemistry 31, 12688-12694
13. Jaynes, J.M., Julian, G.R., Jeffers, G.W., White, K.L. & Enright, F.M. (1989) Pept. Res. 2, 157-160
14. Lincke, C.R., van der Bliek, A.H., Schuurhuis, G.J., van der Velde-Koerts, T., Smitt, J.J.M. & Borst, P. (1990) Cancer Res. 50, 1779-1785
15. Cruciani, R.A., Baker, J.L., Zasloff, M., Chen, H.C. & Colemonici, O. (1991) Proc. Natl. Acad. Sci. USA 88, 3792-3796
16. King, D.S., Field, C.G. & Fields, G.B. (1990) Int. J. Pept. Protein Res. 36, 255-266
17. Hill, J.A., Annan, R.S. & Biemann, K. (1991) Rapid Commun. Mass Spectrometry 5, 395-399
18. Minna, J.D., Ihde, D.C. & Glatstein, E.J. (1986) N. Engl. J. Med. 315, 1411-1414
19. Johnson, B.E., Grayson, J., Makuch, R.W., Linnoila, I., Anderson, M.J., Cohen, M.H., Glastein, E., Minna, J.D. & Ihde, D.C. (1990) J. Clin. Oncol. 8, 396-401
20. Osterline, K., Hansen, H.H. & Hansen, M. (1986) J. Clin. Oncol. 4, 1307-1313
21. Op den Kamp, J.A.F. (1979) Annu. Rev. Biochem. 48, 47-71
22. Peck-Miller, K.A., Blake, J., Cosand, W.L., Darveau, R.P. & Fell, H.P. (1994) Int. J. Pept. Protein Res. 44, 143-151